Skip to main content
. 2012 Apr 27;7(4):e36108. doi: 10.1371/journal.pone.0036108

Figure 3. Survival curves: percentage of survivors over time in a population of 250 HIV+ virtual patients.

Figure 3

30 days after bacterial challenge survival rates are the following: continuous therapy 91.53%, optimal therapy 90%, random therapy 81.85% and void therapy 45.38%. A reduction of 40% of the drug intake corresponds to less than 5% reduction in the survival rate.